Medication developments in the treatment of mental illness.
D000293:Adolescent; D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000145:classification / Q000627:therapeutic use*; D000068180:Aripiprazole; D001786:Blood Glucose / Q000187:drug effects; D002648:Child; D003866:Depressive Disorder / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use; D011320:Primary Health Care / Q000592:standards; D015363:Quinolones / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D014150:Antipsychotic Agents; D000068180:Aripiprazole; D001786:Blood Glucose; D010879:Piperazines; D015363:Quinolones; D017367:Selective Serotonin Reuptake Inhibitors